The drug development process is long, complex and costly. Bioanalytical testing services play a crucial role in facilitating this process by analyzing samples at various stages of drug development. Through reliable quantification and characterization of drugs and their metabolites in biological matrices like plasma, serum, urine etc., bioanalytical testing helps evaluate pharmacokinetic and pharmacodynamic properties of drug candidates.

Role in Drug Development

Bioanalytical testing services are involved right from the preclinical phase of drug development. During drug discovery and candidate selection, in vitro and in vivo studies are conducted to understand drug metabolism and toxicity. Bioanalysis helps quantify drug levels in biological samples collected during these studies.

At the clinical trial phase, Bioanalytical Testing Services becomes critical for evaluating drug performance in humans. Samples collected during different clinical phases are tested to determine pharmacokinetic parameters like absorption, distribution, metabolism and excretion of the drug. This data is vital for dose optimization and selection of drug candidates for further development.

Bioequivalence and Bioavailability Studies

For generic drug approval, bioequivalence and bioavailability studies are mandatory to prove therapeutic equivalence to an innovator drug. Testing services conduct comparative analyses of generic formulations with the reference drug to establish bioequivalence.

Samples from in vivo bioequivalence and bioavailability studies are analyzed to compare rate and extent of absorption of both drugs. If results fall within predefined limits, generic versions can be approved as substitutes. This expands treatment access by reducing costs.

Analytical Method Development and Validation

Developing robust, selective and sensitive analytical methods is essential for quantitative bioanalysis. Leading testing labs invest heavily in this area to provide fit-for-purpose methods validated as per international regulatory guidelines.

Method development involves optimizing extraction procedures and chromatographic/mass spectroscopic parameters to separate analytes from matrix interference. Method validation establishes parameters like accuracy, precision, selectivity, sensitivity, reproducibility, matrix effect and stability. Only validated methods can be deployed for regulated bioanalysis.

Compliance with Quality Standards

Being at the core of drug development, bioanalytical testing services require stringent compliance with quality standards. Accreditation by reputed organizations like College of American Pathologists, CLIA demonstrates technical competence.

Adherence to Good Laboratory Practice guidelines and other regulatory norms ensures generating reliable data acceptable to health authorities. Advanced LIMS systems maintain sample chain of custody and analytical data for regulatory inspection. Quality controls minimize errors to safeguard patient safety.

Get More Insights On This Topic: Bioanalytical Testing Services

Explore More Related Topic: Global Paclitaxel Injection Market